01/11/2014 08:43:47 Free Membership Login

Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Cla...

Date : 11/21/2012 @ 12:07AM
Source : PR Newswire (US)
Stock : Peregrine Pharmaceuticals Inc. (MM) (PPHM)
Quote : 1.6  0.04 (2.56%) @ 5:40AM
Peregrine Pharmaceuticals Inc. (MM) share price Chart

Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Cla...

Peregrine Pharmaceuticals Inc. (MM) (NASDAQ:PPHM)
Historical Stock Chart

2 Years : From Nov 2012 to Nov 2014

Click Here for more Peregrine Pharmaceuticals Inc. (MM) Charts.
Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Peregrine Pharmaceuticals, Inc. (PPHM)

NEW YORK, Nov. 20, 2012 /PRNewswire/ -- 

(Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.

JDA Software Group Inc.
Levi & Korsinsky is investigating the Board of Directors of JDA Software Group Inc. (NasdaqGS: JDAS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to RedPrairie Corp. for $45 per share.

Click here to learn more about the investigation http://zlk.9nl.com/jda-software, or call: 877-363-5972.

Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.

For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.   

Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.

For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm.  You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 

SOURCE Levi & Korsinsky, LLP

Copyright 2012 PR Newswire



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 in 141101 08:43